A recent study by Nagoya University researchers revealed that microRNAs in urine could be a promising biomarker to diagnose brain tumors. Their findings, published in the journal ACS Applied Materials & Interfaces, have indicated that regular urine tests could...
As we all know, there continues to be a dire need for new treatment options for diffuse midline gliomas #DMG A breakthrough in recent years have shown that many DMGs have a specific K27M mutation on Histone protein H3. What are histones? Histones bind, unwrap or...
– Chia-Yi, Hou Changing America Glioblastoma is a type of cancer that can form in the brain or spinal cord. The drugs used in the clinical trial are atezolizumab, an immunotherapy drug, and ipatasertib, a new precision drug that “may be able to uncloak tumours...
-MORNING EDITION, NPR NEWS Lots of people have questions about getting vaccinated against COVID-19. That includes the millions of Americans with weakened immune systems that put them at higher risk of severe disease if they do get infected with the coronavirus....
Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typical of cancer. A vaccine can alert the patient’s immune system to these mutated proteins. For the first time, physicians and cancer...
Summary Background Cisplatin is used to treat a wide range of childhood cancers and cisplatin-induced hearing loss (CIHL) is a common and debilitating toxicity. We aimed to address persistent knowledge gaps in CIHL by establishing benchmarks for the prevalence of and...
No matter where you are in your journey, CBTF is here to help. If you’re interested in finding out more about CBTF programming and support, please fill out our form to be connected to our team.
